US FDA approves Roivant-Priovant’s skin and muscle disease drug
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
Finance, IT & News
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients CNBC
FDA approves Roivant therapy for rare autoimmune disease STAT
FDA issues Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis)…
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.